South Africa’s healthcare economy is entering its most commercially concentrated phase yet, with global medical technology manufacturers accelerating their push for market share in a region now valued at over R18.4 billion (USD 1.12 billion) in medical devices alone and on track to reach R27.4 billion (USD 1.67 billion) by 2032[1]. According to the WHX Insights MedTech Report Unlocking Africa’s Medical Technology Potential, Africa’s broader medtech market is projected to grow from R186.1 billion (USD 11.33 billion) in 2025 to R251.7 billion (USD 15.33 billion) by 2030, driven by rapid urbanisation, rising non-communicable disease burdens and expanding private healthcare investment. At the centre of this commercial surge is Johannesburg, home to the headquarters, procurement teams and distributor networks that control access to theSouthern African Development Community (SADC) region’s fastest-growing healthcare markets.